All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAART-LX291 | Anti-Cytokeratin 19 (BA-17) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | BA-17 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX292 | Anti-Cytokeratin 19 (E6) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | E6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX293 | Anti-Cytokeratin 19 (EP1580Y) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | EP1580Y | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX294 | Anti-Cytokeratin 19 (A53-B/A2) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | A53-B/A2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX295 | Anti-Cytokeratin 19 (A-3) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | A-3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX296 | Anti-Cytokeratin 19 (3F8) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | 3F8 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX297 | Anti-Cytokeratin 19 (ABT-CK19) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | ABT-CK19 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX298 | Anti-Cytokeratin 19 (LE64) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | LE64 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX299 | Anti-Cytokeratin 19 (BA-17) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | BA-17 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX300 | Anti-Cytokeratin 19 (E6) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | E6 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX301 | Anti-Cytokeratin 19 (EP1580Y) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | EP1580Y | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX302 | Anti-Cytokeratin 19 (A53-B/A2) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | A53-B/A2 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX303 | Anti-Cytokeratin 19 (A-3) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | A-3 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX304 | Anti-Cytokeratin 19 (3F8) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | 3F8 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX305 | Anti-Cytokeratin 19 (ABT-CK19) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | ABT-CK19 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX306 | Anti-Cytokeratin 19 (LE64) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | LE64 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION